210
Participants
Start Date
April 12, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Pregabalin 50mg
Patients will receive 50 mg every 8 hours without dose titration. Patients with CrCl \< 60mL/min will receive same dose given q12 hours. The q12 hour regimen may be increased to q8 hours if CrCl increases above 60mL/min during the 7 days study period or until discharge (if \< 7 days post-enrollment).
Gabapentin 300mg
Patients will receive 300 mg PO every 8 hours without dose titration. Patients with CrCl \< 60mL/min will receive same dose given q12 hours. The q12 hour regimen may be increased to q8 hours if CrCl increases above 60mL/min during the 7 days study period or until discharge (if \< 7 days post-enrollment).
Neither Pregabalin nor Gabapentin
Patients will receive neither Pregabalin nor Gabapentin.
RECRUITING
"Charleston Area Medical Centers Level 1 Trauma Center", Charleston
CAMC Health System
OTHER